231 related articles for article (PubMed ID: 9704382)
1. VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione.
Hishida R; Nau H
Teratog Carcinog Mutagen; 1998; 18(2):49-61. PubMed ID: 9704382
[TBL] [Abstract][Full Text] [Related]
2. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
Dawson JE; Raymond AM; Winn LM
Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
[TBL] [Abstract][Full Text] [Related]
3. Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice.
Spiegelstein O; Merriweather MY; Wicker NJ; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):974-8. PubMed ID: 14745917
[TBL] [Abstract][Full Text] [Related]
4. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
Massa V; Wlodarczyk B; Giavini E; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
[TBL] [Abstract][Full Text] [Related]
5. [Morphological changes induced by valproate and its administration concomitant with folinic acid or S-adenosylmethionine in pregnant rats].
Ubeda-Martín N; Alonso-Aperte E; Achón M; Varela-Moreiras G; Puerta J; Pérez de Miguelsanz J
Nutr Hosp; 1998; 13(1):41-9. PubMed ID: 9578686
[TBL] [Abstract][Full Text] [Related]
6. Teratogenicity of valproate conjugates with anticonvulsant activity in mice.
Spiegelstein O; Chatterjie N; Alexander G; Finnell RH
Epilepsy Res; 2003 Dec; 57(2-3):145-52. PubMed ID: 15013055
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
8. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
Gravemann U; Volland J; Nau H
Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
[TBL] [Abstract][Full Text] [Related]
9. Multiple point action mechanism of valproic acid-teratogenicity alleviated by folic acid, vitamin C, and N-acetylcysteine in chicken embryo model.
Hsieh CL; Wang HE; Tsai WJ; Peng CC; Peng RY
Toxicology; 2012 Jan; 291(1-3):32-42. PubMed ID: 22051200
[TBL] [Abstract][Full Text] [Related]
10. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
Padmanabhan R; Hameed MS
J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
[TBL] [Abstract][Full Text] [Related]
11. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
Hansen DK; Grafton TF; Dial SL; Gehring TA; Siitonen PH
Teratology; 1995 Nov; 52(5):277-85. PubMed ID: 8838251
[TBL] [Abstract][Full Text] [Related]
12. Acute valproate administration impairs methionine metabolism in rats.
Ubeda N; Alonso-Aperte E; Varela-Moreiras G
J Nutr; 2002 Sep; 132(9):2737-42. PubMed ID: 12221238
[TBL] [Abstract][Full Text] [Related]
13. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M
Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722
[TBL] [Abstract][Full Text] [Related]
14. Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice.
Okada A; Kushima K; Aoki Y; Bialer M; Fujiwara M
Birth Defects Res A Clin Mol Teratol; 2005 Apr; 73(4):229-38. PubMed ID: 15799026
[TBL] [Abstract][Full Text] [Related]
15. Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: correlation with neural tube defect formation in the mouse.
Nau H
Teratology; 1986 Feb; 33(1):21-7. PubMed ID: 3090732
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine is embryotoxic but does not cause neural tube defects in mouse embryos.
Greene ND; Dunlevy LE; Copp AJ
Anat Embryol (Berl); 2003 Feb; 206(3):185-91. PubMed ID: 12592569
[TBL] [Abstract][Full Text] [Related]
17. Amidic modification of valproic acid reduces skeletal teratogenicity in mice.
Okada A; Kurihara H; Aoki Y; Bialer M; Fujiwara M
Birth Defects Res B Dev Reprod Toxicol; 2004 Feb; 71(1):47-53. PubMed ID: 14991910
[TBL] [Abstract][Full Text] [Related]
18. Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos.
Padmanabhan R; Shafiullah M; Benedict S; Nagelkerke N
Eur J Nutr; 2006 Sep; 45(6):311-9. PubMed ID: 16699836
[TBL] [Abstract][Full Text] [Related]
19. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I).
Sato M; Shirota M; Nagao T
Teratology; 1995 Sep; 52(3):143-8. PubMed ID: 8638254
[TBL] [Abstract][Full Text] [Related]
20. Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid.
Steen MT; Boddie AM; Fisher AJ; Macmahon W; Saxe D; Sullivan KM; Dembure PP; Elsas LJ
Prenat Diagn; 1998 Jun; 18(6):545-55. PubMed ID: 9664599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
